Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies
- PMID: 23202802
- PMCID: PMC4011611
- DOI: 10.1038/aps.2012.146
Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies
Abstract
Aim: To investigate the molecular mechanisms underlying the influence of DNA polymerase from different genotypes of hepatitis B virus (HBV) on the binding affinity of adefovir (ADV).
Methods: Computational approaches, including homology modeling, docking, MD simulation and MM/PBSA free energy analyses were used.
Results: Sequence analyses revealed that residue 238 near the binding pocket was not only a polymorphic site but also a genotype-specific site (His238 in genotype B; Asn238 in genotype C). The calculated binding free-energy supported the hypothesis that the polymerase from HBV genotype C was more sensitive to ADV than that from genotype B. By using MD simulation trajectory analysis, binding free energy decomposition and alanine scanning, some energy variation in the residues around the binding pocket was observed. Both the alanine mutations at residues 236 and 238 led to an increase of the energy difference between genotypes C and B (ΔΔG(C-B)), suggesting that these residues contributed to the genotype-associated antiviral variability with regard to the interaction with ADV.
Conclusion: The results support the hypothesis that the HBV genotype C polymerase is more sensitive to ADV than that from genotype B. Moreover, residue N236 and the polymorphic site 238 play important roles in contributing to the higher sensitivity of genotype C over B in the interaction with ADV.
Figures







Similar articles
-
Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance.Curr Med Chem. 2015;22(34):3922-32. doi: 10.2174/0929867322666150904144802. Curr Med Chem. 2015. PMID: 26336997
-
Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.J Viral Hepat. 2004 Jan;11(1):74-83. doi: 10.1046/j.1365-2893.2003.00471.x. J Viral Hepat. 2004. PMID: 14738561 Clinical Trial.
-
HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.Liver Int. 2014 Aug;34(7):1025-32. doi: 10.1111/liv.12343. Epub 2013 Nov 20. Liver Int. 2014. PMID: 24118725
-
[Research on molecular mechanism of drug resistance of adefovir dipivoxil].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Feb;29(1):184-7. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012. PMID: 22404035 Review. Chinese.
-
Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B.J Viral Hepat. 1999 May;6(3):183-94. doi: 10.1046/j.1365-2893.1999.00160.x. J Viral Hepat. 1999. PMID: 10607230 Review.
Cited by
-
Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.Molecules. 2017 May 19;22(5):840. doi: 10.3390/molecules22050840. Molecules. 2017. PMID: 28534839 Free PMC article.
-
Conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1.Acta Pharmacol Sin. 2017 Dec;38(12):1673-1682. doi: 10.1038/aps.2017.37. Epub 2017 Jul 27. Acta Pharmacol Sin. 2017. PMID: 28748916 Free PMC article.
-
Structure-based ensemble-QSAR model: a novel approach to the study of the EGFR tyrosine kinase and its inhibitors.Acta Pharmacol Sin. 2014 Feb;35(2):301-10. doi: 10.1038/aps.2013.148. Epub 2013 Dec 16. Acta Pharmacol Sin. 2014. PMID: 24335842 Free PMC article.
-
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.PLoS One. 2015 Aug 31;10(8):e0136728. doi: 10.1371/journal.pone.0136728. eCollection 2015. PLoS One. 2015. PMID: 26322642 Free PMC article.
-
Small Molecule Drugs Targeting Viral Polymerases.Pharmaceuticals (Basel). 2024 May 20;17(5):661. doi: 10.3390/ph17050661. Pharmaceuticals (Basel). 2024. PMID: 38794231 Free PMC article. Review.
References
-
- Zoulim F, Parvaz P, Marcellin P, Zarski JP, Beaugrand M, Benhamou Y, et al. Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure. Liver Int. 2009;29:420–6. - PubMed
-
- Tanwar S, Dusheiko G. Is there any value to hepatitis B virus genotype analysis. Curr Gastroenterol Rep. 2012;14:37–46. - PubMed
-
- Chu CM, Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol. 2005;43:411–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical